Skip to main content
MedPathMedPath Home
Clinical Trials/NCT03618875
NCT03618875
Completed
Not Applicable

Reduction of Post Intravitreal Injection Bleeding and Pain by Ice

Wolfson Medical Center1 site in 1 country40 target enrollmentJanuary 1, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pain
Sponsor
Wolfson Medical Center
Enrollment
40
Locations
1
Primary Endpoint
pain
Status
Completed
Last Updated
7 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

Intravitreal injections are an efficient method for delivering intraocular therapeutic agents in numerous ophthalmologic diseases. However, side effects, such as pain and subconjunctival hemorrhage remain a major concern.

Prevention or alleviation of those side effects might shorten the healing duration and improve patients' quality of life.

Detailed Description

cooling the eye using ice patched prior to Intravitreal injections may ameliorated pain and subconjunctival hemorrhage incidences.

Registry
clinicaltrials.gov
Start Date
January 1, 2017
End Date
November 25, 2017
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •patients receiving intravitreal injection

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

pain

Time Frame: change between VAS pain score at baseline and 10 minutes

Visual Analogue Scale (VAS) is a Likert-type scale (1-10). The VAS is a reliable tool in evaluating and quantifying ocular discomfort

Secondary Outcomes

  • size of subconjunctival hemorrhage(change between subconjunctival hemorrhage at baseline and 10 minutes)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Pain Control and Subconjunctival Hemorrhage Size After Intravitreal InjectionIntravitreal InjectionPainSubconjunctival Hemorrhage
NCT04827836Wolfson Medical Center100
Recruiting
Not Applicable
Endophthalmitis Post Intravitreal InjectionsEndophthalmitis
NCT04035369Unity Health Toronto310
Completed
Phase 4
Control of Pain in Intravitreal Injections Using Topical NSAIDsIntravitreal InjectionsIVI
NCT04343222University of Wisconsin, Madison46
Completed
Not Applicable
Intravitreal Triamcinolone and Moxifloxacin Injection After Cataract SurgeryPharmacological Action
NCT05428683Emad Abdel Aal Saliem84
Enrolling By Invitation
Not Applicable
Implementation of the Intravitreal Injection Administered by NursesMacular EdemaMacular DegenerationDiabetic Macular Edema
NCT06511700Corporacion Parc Tauli200